on October 19, 2007
Published online before print October 11, 2007, doi: 10.1161/ATVBAHA.107.153734
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 17, 2007
Accepted on September 7, 2007
Activated Protein C Decreases Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand by an EPCR Independent Mechanism Involving Egr-1/Erk-1/2 Activation
Lee A. O'Brien ;
From the Division of Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Ind.
* To whom correspondence should be addressed. E-mail: bgrinnell{at}lilly.com.
Background—APC is an antithrombotic and antiinflammatory serine protease that plays an important role in vascular function. We report that APC can suppress the proapoptotic mediator TRAIL in human umbilical vein endothelial cells, and we have investigated the signaling mechanism.
Methods and Results—APC inhibited endothelial TRAIL expression and secretion and its induction by cell activation. To explore the mechanism, we examined factors associated with TRAIL regulation and demonstrated that APC increased the level of EGR-1, a transcriptional factor known to suppress the TRAIL promoter. APC also induced a significant increase in phosphorylation of ERK-1/2, required to activate EGR-1 expression. Activation of ERK-1/2 was dependent on the protease activated receptor-1 (PAR-1), but independent of the endothelial protein C receptor (EPCR). Using siRNA, we found that the effect of APC on the EGR-1/ERK signaling required for TRAIL inhibition was dependent on the S1P1 receptor and S1P1 kinase.
Conclusions—Our data suggest that APC may provide cytoprotective activity by activating the ERK pathway, which upregulates EGR-1 thereby suppressing the expression of TRAIL. Moreover, we provide evidence that APC can induce a cell signaling response through a PAR-1/S1P1-dependent but EPCR-independent mechanism.
Key words: endothelial protein C receptor • apoptosis • protease activated receptor • APC • TRAIL
Related Article:
- Protective Signaling Pathways of Activated Protein C in Endothelial Cells
- Matthias Riewald and Reto A. Schuepbach
Arterioscler Thromb Vasc Biol 2008 28: 1-3.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
 |
|
 |
|
  S. Simoncini, M.-S. Njock, S. Robert, L. Camoin-Jau, J. Sampol, J.-R. Harle, C. Nguyen, F. Dignat-George, and F. Anfosso TRAIL/Apo2L Mediates the Release of Procoagulant Endothelial Microparticles Induced by Thrombin In Vitro: A Potential Mechanism Linking Inflammation and Coagulation Circ. Res., April 24, 2009; 104(8): 943 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gupta, B. Gerlitz, M. A. Richardson, C. Bull, D. T. Berg, S. Syed, E. J. Galbreath, B. A. Swanson, B. E. Jones, and B. W. Grinnell Distinct Functions of Activated Protein C Differentially Attenuate Acute Kidney Injury J. Am. Soc. Nephrol., February 1, 2009; 20(2): 267 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. V. Yang, Y. Banerjee, J. A. Fernandez, H. Deguchi, X. Xu, L. O. Mosnier, Rolf. T. Urbanus, P. G. de Groot, T. C. White-Adams, O. J. T. McCarty, et al. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells PNAS, January 6, 2009; 106(1): 274 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Toltl, S. Beaudin, P. C. Liaw, and and the Canadian Critical Care Translational Biolo Activated Protein C Up-Regulates IL-10 and Inhibits Tissue Factor in Blood Monocytes J. Immunol., August 1, 2008; 181(3): 2165 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Secchiero and G. Zauli The Puzzling Role of TRAIL in Endothelial Cell Biology Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): e4 - e4. [Full Text] [PDF]
|
|
|
|
|
|
L. A. O'Brien, M. A. Richardson, D. T. Berg, B. Gerlitz, A. Gupta, and B. W. Grinnell The Puzzling Role of TRAIL in Endothelial Cell Biology Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): e5 - e6. [Full Text] [PDF]
|
|
|
|
|
|
M. Riewald and R. A. Schuepbach Protective Signaling Pathways of Activated Protein C in Endothelial Cells Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 1 - 3. [Full Text] [PDF]
|
|